Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene

Acta Myologica

Volumn 34, Issue 1, 2015, Pages 9-13

  Taglia, Antonella ^a   Petillo, Roberta ^a   D'Ambrosio, Paola ^a   Picillo, Esther ^a   Torella, Annalaura ^b   Orsini, Chiara ^a   Ergoli, Manuela ^a   Scutifero, Marianna ^a   Passamano, Luigia ^a   Palladino, Alberto ^a   Nigro, Gerardo ^a   Politano, Luisa ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b A O V CERVELLO   (Italy)

Author keywords

Asymptomatic BMD; Becker muscular dystrophy; Dystrophin

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; CLINICAL FEATURE; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE DELETION; GENE MUTATION; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PHENOTYPE; PRESCHOOL CHILD; PROGNOSTIC ASSESSMENT; RETROSPECTIVE STUDY; SCHOOL CHILD; BLOOD; EXERCISE TOLERANCE; GENETICS; METABOLISM; MUSCLE CRAMP; MUSCULAR DYSTROPHY, DUCHENNE; MYALGIA; MYOGLOBINURIA; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROGNOSIS; YOUNG ADULT;

CREATINE KINASE; DMD PROTEIN, HUMAN; DYSTROPHIN; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CREATINE KINASE; DYSTROPHIN; EXERCISE TOLERANCE; EXONS; GENETIC COUNSELING; HUMANS; MIDDLE AGED; MUSCLE CRAMP; MUSCULAR DYSTROPHY, DUCHENNE; MYALGIA; MYOGLOBINURIA; PROGNOSIS; RETROSPECTIVE STUDIES; RNA, MESSENGER; SEQUENCE DELETION; YOUNG ADULT;

EID: 84946099505     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003;2:731-40.
2. Sadoulet-Puccio HM, Kunkel LM. Dystrophin and its isoforms. Brain Pathol 1996;6:25-35.
3. Surono A, Takeshima Y, Wibawa T, et al. Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing. Hum Mol Genet 1999;8:493-500.
4. Blake DJ, Weir A, Newey SE, et al. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002;82:291-329.
5. Koenig M, Monaco AP, Kunkel LM. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 1988;53:219-28.
6. Le Rumeur E, Winder SJ, Hubert JF. Dystrophin: more than just the sum of its parts. Biochim Biophys Acta 2010;1804:1713-22.
7. Norwood FL, Sutherland-Smith AJ, Keep NH, et al. The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy. Structure 2000;8:481-91.
8. Winder SJ, Gibson TJ, Kendrick-Jones J. Dystrophin and utrophin: the missing links. FEBS Lett. 1995;369:27-33.
9. Jung D, Yang B, Meyer J, Chamberlain JS, et al. Identification and characterization of the dystrophin anchoring site on betadystroglycan. J Biol Chem 1995;270:27305-10.
10. Yang B, Jung D, Rafael JA, et al. Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin. J Biol Chem 1995;270:4975-8.
11. Ahn AH, Kunkel LM. Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol 1995;128:363-71
12. Rando TA. The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 2001;24:1575-94.
13. Campbell KP, Kahl SD. Association of dystrophin and an integral membrane glycoprotein. Nature 1989;338:259-62.
14. Petrof BJ. Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am J Phys Med Rehabil 2002;81:S162-74.
15. Monaco AP, Bertelson CJ, Liechti-Gallati S, et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988;2:90-5.
16. Mühlemann O, Eberle AB, Stalder L, et al. Recognition and elimination of nonsense mRNA. Biochim Biophys Acta 2008;1779:538-49.
17. Angelini C, Fanin M, Freda MP, et al. Prognostic factors in mild dystrophinopathies. J Neurol Sci 1996;142:70-8.
18. Beggs AH, Hoffman EP, Snyder JR, et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet 1991;49:54-67.
19. Gospe SM Jr, Lazaro RP, Lava NS, et al. Familial X-linked myalgia and cramps: a non progressive myopathy associated with a deletion in the dystrophin gene. Neurology 1989;39:1277-80.
20. Melis MA, Cau M, Muntoni F, et al. Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families. Eur J Paediatr Neurol 1998;2:255-61.
21. Arahata K, Beggs AH, Honda H, et al. Preservation of the Cterminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. J Neurol Sci 1991;101:148-56.
22. Winnard AV, Mendell JR, Prior TW, et al. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet 1995;56:158-66.
23. Nevo Y, Muntoni F, Sewry C, et al. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype. Isr Med Assoc J 2003;5:94-7.
24. Roberts RG, Gardner RJ, Bobrow M. Searching for the 1 in 2, 400, 000: a review of dystrophin gene point mutations. Hum Mutat 1994;4:1-11.
25. Cox GF, Kunkel LM. Dystrophies and heart disease. Curr Opin Cardiol 1997;12:329-43.
26. Connuck DM, Sleeper LA, Colan SD, et al. Pediatric Cardiomyopathy Registry Study Group; Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 2008;155:998-1005.
27. Bushby KM. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms. Hum Mol Genet 1999;8:1875-82.
28. Melacini P, Fanin M, Danieli GA, et al. Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 1996;94:3168-75.
29. Saito M, Kawai H, Akaike M, et al. Cardiac dysfunction with Becker muscular dystrophy. Am Heart J 1996;132:642-7.
30. Nicolas A, Raguénès-Nicol C, Ben Yaou R, et al. French Network of Clinical Reference Centres for Neuromuscular Diseases (CORNEMUS). Becker muscular dystrophy severity is linked to the structure of dystrophin. Hum Mol Genet 2015;24:1267-79.
31. Beroud C, Tuffery-Giraud S, Matsuo M, et al. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy. Hum Mutat 2007;28:196-202.
32. Ferreiro V, Giliberto F, Muniz GM, et al. Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion. Muscle Nerve 2009;39:239-43.
33. Miyazaki D, Yoshida K, Fukushima K, et al. Characterization of deletion breakpoints in patients with dystrophinopathy carrying a deletion of exons 45-55 of the Duchenne muscular dystrophy (DMD) gene. J Hum Genet 2009;54:127-30.
34. Nakamura A, Yoshida K, Fukushima K, et al. Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene. J Clin Neurosci 2008;15:757-63.
35. Anthony K, Cirak S, Torelli S, et al. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain 2011;134(Pt 12):3547-59.
36. Comi GP, Prelle A, Bresolin N, et al Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates. Brain 1994;117:1-14.
37. Magri F, Govoni A, D'Angelo MG, et al. Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J Neurol 2011;258:1610-23.
38. Nigro G, Comi L, Politano L, et al. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve 1995;18:283-91.
39. Mansi L, Pace L, Politano L, et al. Left ventricular function and perfusion in Becker's muscular dystrophy. J Nucl Med 1997;38:563-7.
40. Agretto A, Politano L, Bossone E, et al. Pulsed Doppler tissue imaging in dystrophinopathic cardiomyopathy. J Am Soc Echocardiogr 2002;15:891-9.
41. Cittadini A, Ines Comi L, Longobardi S, et al. A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies. Eur Heart J 2003;24:664-72.
42. Ducceschi V, Nigro G, Sarubbi B, et al. Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy. Int J Cardiol 1997;59:275-9.
43. Nigro G, Nigro G, Politano L, et al. Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients. Heart 2002;87:156-7.
44. Nigro G, Politano L, Nigro V, et al. Mutation of dystrophin gene and cardiomyopathy. Neuromuscul Disord 1994;4:371-9.
45. Kaspar RW, Allen HD, Ray WC, et al. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy. Circ Cardiovasc Genet 2009;2:544-51.